Clinical trial
A Double Blind, Randomized, Placebo Controlled Study to Evaluate Efficacy and Safety of "VIRACIDE" in the Management of Corona Virus Disease 2019 (COVID-19)
NCT04596085 is registered in ClinicalTrials.gov with The Herb, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double Blind, Randomized, Placebo Controlled Study to Evaluate Efficacy and Safety of "VIRACIDE" in the Management of Corona Virus Disease 2019 (COVID-19)
- Lead sponsor
- The Herb, Inc
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 16, 2020
- Completion date
- December 12, 2020
- Enrollment
- 118 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
covid19